CLASS II ONGOING Drug recall · Reported 2 Aug 2023 · FDA Enforcement Report

Oxacillin for Injection, USP per vial, For IV or IM Use recalled

Sagent Pharmaceuticals is recalling Oxacillin for Injection, USP per vial, For IV or IM Use, distributed nationwide in the US. The recall was initiated on 11 Jul 2023 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesLot: OXG301, Exp 12/31/2025
Quantity recalled65,710 vials for 1 g and 2 g strength

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

Recall details

Recall number
D-0935-2023
FDA event ID
92678
Recalling firm
Sagent Pharmaceuticals, Schaumburg, IL
Classification
Class II
Status
Ongoing
Recall initiated
11 Jul 2023
FDA classified
21 Jul 2023
Reported
2 Aug 2023
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Sterility

Timeline

11 Jul 2023Recall initiated by company
21 Jul 2023Classified by FDA+10 days
2 Aug 2023Published in enforcement report+12 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Lack of Assurance of Sterility

A sterility recall means a product that must be sterile, such as an injection or eye drop, may be contaminated. Using a non-sterile product can cause serious infection.

Product as listed by the FDA

Oxacillin for Injection, USP, 1 gram per vial, For IV or IM Use, Rx only, Mfd. for SAGENT Pharmaceuticals, Schaumburg, IL 60195. Made in India. NDC 25021-146-10.

Where it was distributed

Nationwide in the USA

Nationwide

Questions about this recall

Why was it recalled?

Lack of Assurance of Sterility

Which lots are affected?

Lot: OXG301, Exp 12/31/2025

Where was it sold?

Nationwide in the USA

What should I do if I have it?

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

Other products in this recall event

2 other products · FDA event 92678

More recalls from Sagent Pharmaceuticals

All 23

Other Oxacillin recalls

All 4